Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Total knee AI/AR cleared for sales in the US

The FDA has granted 510(k) clearance to a French startup for surgery software that combines AI with augmented reality and computer vision.

Thumbnail

Interventional radiologists leading fewer kidney stone removal procedures

While IR experts still complete a majority of initial renal access exams, urologists are narrowing the gap.

Automated tool can help radiologists avoid overlooking wrist fractures on X-ray exams

The AI performed comparably to imaging experts and may best serve as a triage tool or additional reader to reduce the risk of missing a fracture.

‘Partial victory’: Imaging advocates say Humana relenting on some PET/CT payment restrictions

The health insurer reversed its coverage denial for imaging of gastric and esophageal oncologic indications, while other restrictions remain in place. 

COVID-19 vaccine-related imaging tracer uptake may appear weeks after previously thought

Nearly 30% of patients showed lymph node uptake on PET/CT scans more than six weeks after their second dose of the Pfizer-BioNTech vaccine.

New advanced PET approach helps surgeons stop epileptic seizures

University of Virginia School of Medicine researchers reported positive results after using their imaging technique in a small pilot study.

FDA greenlights clinical trials testing novel MRI contrast agent for prostate cancer

Case Western Reserve University developed the gadolinium material, which is expected to be tested in 30 healthy participants beginning later this month.

Thumbnail

Nuclear medicine groups announce new registry to bolster prostate cancer imaging with SPECT

The Nobody Left Behind or NOBLE Registry aims to establish prostate-specific membrane antigen SPECT imaging as a cost-effective and widely available alternative to PSMA-PET.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.